ロード中...
PRIMARY ADRENAL INSUFFICIENCY SECONDARY TO CHRONIC POSACONAZOLE USE
OBJECTIVE: Posaconazole (PSO) is commonly used in the treatment of invasive fungal infections. PSO-induced primary adrenal insufficiency (PAI) is rare, and we present what we think to be the third case report of its incidence. We want to bring awareness to this rare but significant side effect that...
保存先:
| 出版年: | AACE Clin Case Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association of Clinical Endocrinologists
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7282156/ https://ncbi.nlm.nih.gov/pubmed/32524012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0176 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|